Effect of Delivery Route on PK of Sufentanil NanoTab

NCT01639729 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics

Interventions

DRUG: Treatment A: Sufentanil IV
DRUG: Treatment B: Sufentanil NanoTab Sublingual
DRUG: Treatment C: Sufentanil NanoTab Buccal
DRUG: Treatment D: Sufentanil NanoTab Oral

Sponsor

Talphera, Inc